Anna Lindhoff Larsson

Anna Lindhoff Larsson

Auto-generated profile, based on publicly available information

Anna Lindhoff Larsson

Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in HPB
Verified
Journal Article
Open access
KJKarin Johansen
Karin Johansen
ALAnna Lindhoff Larsson
Anna Lindhoff Larsson
LLLinda Lundgren
Linda Lundgren
TGThomas Gasslander
Thomas Gasslander
CHClaes Hjalmarsson
Claes Hjalmarsson
BBBergthor Björnsson
Bergthor Björnsson
Laparoscopic distal pancreatectomy is being implemented worldwide. The aim of this study was to perform a cost-effectiveness analysis from a health care perspective. This cost-effectiveness analysis was based on the randomized controlled trial LAPOP, where 60 patients were randomized to open or laparoscopic distal pancreatectomy. For the follow-up of two years, resource use from a health care perspective was recorded, and health-related quality of life was assessed using the EQ-5D-5L. The per-patient mean cost and quality-adjusted life years (QALYs) were compared using nonparametric bootstrapping. Fifty-six patients were included in the analysis. The mean health care costs were lower, €3863 (95% CI: -€8020 to €385), for the laparoscopic group. Postoperative quality of life improved with laparoscopic resection and resulted in a gain in QALYs of 0.08 (95% CI: -0.09 to 0.25). The laparoscopic group had lower costs and improved QALYs in 79% of bootstrap samples. With a cost-per-QALY threshold of €50 000, 95.4% of the bootstrap samples were in favour of laparoscopic resection. Laparoscopic distal pancreatectomy is associated with numerically lower health care costs and improvements in QALYs compared with the open approach. The results support the ongoing transition from open to laparoscopic distal pancreatectomies.

4 March 2022 in HPB
Verified
Journal Article
Open access
KJKarin Johansen
Karin Johansen
ALAnna Lindhoff Larsson
Anna Lindhoff Larsson
TGThomas Gasslander
Thomas Gasslander
LLLinda Lundgren
Linda Lundgren
KHKristina Hasselgren
Kristina Hasselgren
BBBergthor Björnsson
Bergthor Björnsson
With the poor prognosis of pancreatic cancer and the high rate of postoperative complications after pancreaticoduodenectomy, it is important to evaluate how the operation affects patients' quality of life. This single-centre study included all patients undergoing pancreaticoduodenectomy from 2006 to 2016. Quality of life was measured with two questionnaires preoperatively, and at 6 and 12 months postoperatively. Comparisons between groups were made using a linear mixed models analysis. Of 279 patients planned for pancreaticoduodenectomy, 245 underwent the operation. The postoperative response rates were all 80% or more. Differences were found in one domain between the early and late time periods and three domains between patients receiving and not receiving adjuvant chemotherapy. No significant differences were found between patients with and without severe postoperative complications. However, the demographic variables of age group, sex, preoperative diabetes and smoking all exerted a significant impact on postoperative quality of life. While little or no impact was shown for the factors of postoperative complications, time period and adjuvant chemotherapy, demographic data, such as age, sex, preoperative diabetes and smoking, had considerable impacts on postoperative quality of life after pancreaticoduodenectomy.

20 July 1999 in ChemInform
Verified
Journal Article
Closed access
PDF file
BPB. Anders Persson
B. Anders Persson
ALAnna L. E. Larsson
Anna L. E. Larsson
MRMikael Le Ray
Mikael Le Ray
JBJan.‐E. Baeckvall
Jan.‐E. Baeckvall

17 February 1998 in ChemInform
Verified
Journal Article
Closed access
PDF file
ALA. L. E. Larsson
A. L. E. Larsson
RGR. G. P. Gatti
R. G. P. Gatti
JBJ.‐E. Baeckvall
J.‐E. Baeckvall

28 March 2022
Verified
Conference Paper
Open access
FFFritjof Fagerlund
Fritjof Fagerlund
GNGeorgios Niarchos
Georgios Niarchos
LALutz Ahrens
Lutz Ahrens
DKDan Berggren Kleja
Dan Berggren Kleja
JBJonny Bergman
Jonny Bergman
HPHenning Persson
Henning Persson
Due to their extreme persistence, often combined with high aqueous mobility, per- and polyfluoroalkyl substances (PFAS) are challenging to remediate and remove from the environment. Stabilisation by activated carbon is a method that can potentially stop or at least reduce the migration of PFAS and limit further spreading to the environment from contaminated hot spots. In the StopPFAS project, the use of sorbents to limit PFAS migration in groundwater has been investigated, including in a field trial of colloidal activated carbon (CAC) injection at a PFAS contaminated site in Arboga, Sweden. After CAC injection at the field site, there was an initial reduction in PFAS concentrations by approximately 72% for a sum of 11 PFAS. This indicates significant reduction, but that there were still flow paths where the PFAS transport was not intercepted by CAC. Later however, the PFAS concentrations rebounded to levels equal or higher than before CAC injection. After the rebound concentrations again declined to lower than before CAC injection. The reduction in PFAS concentrations by sorption is related to the amount of CAC that the PFAS come in contact with. A sorptive barrier application is likely to be less effective if the CAC emplacement is uncertain or does not reach all flow paths, if the contaminant transport is dominated by a few preferential flow channels or if the barrier is bypassed due to changes in flow directions. Furthermore, our laboratory experiments indicate that competition with natural organic matter (NOM) does not have a large net effect on the PFAS sorption to CAC on the site. The most reasonable explanation to the post-CAC-injection changes in downstream PFAS concentrations was deemed to be changes in the groundwater flow direction causing bypass or partial bypass of the injected CAC. It was concluded that the distribution of CAC in the subsurface and the extent to which CAC intercepts the PFAS-transporting groundwater are critical to the reduction in PFAS concentrations leaving the contaminated site. The soil characteristics including texture, heterogeneity and existence of preferential flow channels are important factors for the resulting CAC distribution. In a treatment with CAC to limit PFAS migration the goal is to catch as much as possible of the contaminant transport with the injected CAC. Our results show that complex hydrogeological conditions pose a challenge to this goal. For optimal design and placement of a sorptive CAC barrier, it is essential to have a detailed characterization and understanding of soil conditions, groundwater flow directions, including seasonal variations, and flux-zone locations on the local scale of flow through and around the CAC barrier.

13 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
CSChristian Simonsson
Christian Simonsson
WBWolf Claus Bartholomä
Wolf Claus Bartholomä
ALAnna Lindhoff Larsson
Anna Lindhoff Larsson
MKMarkus Karlsson
Markus Karlsson
SCShan Cai
Shan Cai
PLPeter Lundberg
Peter Lundberg
Background & Aims: For a range of liver malignancies, the only curative treatment option may be hepatectomy, which may have fatal complications. Therefore, an unbiased pre-operative risk assessment is vital, however, at present the assessment is typically based on global liver function only. Magnetic resonance imaging (MRI) modalities have the possibility to aid this assessment, by introducing additional characterization of liver parenchymal, such as non-invasive quantification of steatosis, fibrosis, and uptake function, both for global and regional assessment. To this cause, we here present a prospective observation study (LIFE), in which patients underwent extensive MR-examinations both before and after resective-surgery. Approach and Results: A total of 13 patients undergoing hepatectomy underwent a pre- (n=13) and post (m=5) multimodal MRI examination (within 3-5 days of the surgery) (Fig. 1B). The multimodal MR-examination included DCE, 3D-MRE, fat fraction measurements (PDFF by MRS, 6PD). Using these measurements, we also construct individual patient profiles by including conventional functional, and volumetric measurements, into a multi-parametric space. As a proof of concept, the areas of each profile, denoted ‘multiparametric profile area’ (MPA, and aMPA) were calculated, to create a measurement comprising information from all modalities. At a group-level, no clear pattern emerged of MPA or aMPA between groups with different extent of resection. In contrast, on a case-by-case basis, several parameters contributed to high individual MPA or aMPA-values, suggesting tissue abnormalities. With respect to regional DCE measurements, i.e ., relative enhancement at 20 minutes, a clear variation between function in segments, within and between the individuals, was observed. Conclusions: In this combined pre- and post-observational case-based study ranging from very extensive (i) liver surgery to minor (ii), or none (iii), we aimed to describe how a multi-modal MRI examination before hepatectomy could yield valuable information for the pre-operative assessment, with a particular focus on a Couinaud-segmental level. The use of a multi-modal approach allows for a broad spectral characterization of several aspects of the remnant tissue. However, the effectiveness and clinical benefit of each parameter, and how to further optimize an abbreviated clinical MR-protocol needs to be confirmed.